Andrea Isidori to Hydrocortisone
This is a "connection" page, showing publications Andrea Isidori has written about Hydrocortisone.
Connection Strength
1.459
-
Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection. Lancet Diabetes Endocrinol. 2020 06; 8(6):472-473.
Score: 0.393
-
Once-daily, modified-release hydrocortisone in patients with adrenal insufficiency - Authors' reply. Lancet Diabetes Endocrinol. 2018 04; 6(4):270-271.
Score: 0.341
-
Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas. Eur J Endocrinol. 2018 May; 178(5):501-511.
Score: 0.339
-
Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial. Lancet Diabetes Endocrinol. 2018 03; 6(3):173-185.
Score: 0.334
-
Recovery of the Hypothalamo-Pituitary-Adrenal Axis After Transsphenoidal Adenomectomy for Non-ACTH-Secreting Macroadenomas. J Clin Endocrinol Metab. 2019 11 01; 104(11):5316-5324.
Score: 0.024
-
Mortality data from the European Adrenal Insufficiency Registry-Patient characterization and associations. Clin Endocrinol (Oxf). 2018 07; 89(1):30-35.
Score: 0.021
-
How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome? Clin Endocrinol (Oxf). 2000 Oct; 53(4):493-500.
Score: 0.006